27 reports

One such project, led by Dr.

  • Neurological Disorder
  • Neurology
  • Stroke
  • United States
  • UCB S.A.

In this trial, over ## patients will be randomized to receive one of four treatments ## mg ITI-##, ## mg ITI-##, ## mg risperidone (active control) or placebo in a ##:##:##:## ratio.

  • Neurological Disorder
  • Neurology
  • Pharmaceutical
  • Therapy
  • BrainStorm Cell Therapeutics Inc.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Neurology
  • Stroke
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Chronic Pain
  • Neurology
  • Stroke
  • World
  • Pain Therapeutics

After the baseline Phase, patients will be randomized (##:##:##) to receive one of two doses of ZYN## or placebo for ## weeks.

  • Neurology
  • Stroke
  • United States
  • Product Initiative
  • BrainStorm Cell Therapeutics Inc.

One external remote patient monitoring device consists of one external module or transmitter.

  • Cardiovascular Disease
  • Neurology
  • Stroke
  • United States
  • Pfizer Inc.

## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ##

  • Drug Development
  • Monoclonal Antibody
  • Neurology
  • World
  • Product Initiative

It offers products such as antirheumatic agent, antibacterial agent, antiviral agent and antifungal agent.

  • Neurology
  • Stroke
  • Japan
  • M&A
  • Taisho Pharmaceutical Co., Ltd.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Neurology
  • Pharmaceutical
  • Stroke
  • World

The prominent features of this report are - ##.

  • Chronic Pain
  • Neurology
  • Stroke
  • World
  • Product Initiative

Merck is a US-based pharmaceutical company, while Santen Pharmaceutical Co., Ltd. is a Japan-based company engaged in the research, development, manufacturing, and marketing of ophthalmic and antirheumatic pharmaceuticals.

  • Diabetes
  • Neurology
  • Pharmaceutical
  • Stroke
  • Merck & Co., Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Neurology
  • Opioid
  • Stroke
  • Pain Therapeutics

Each of the ##, ## shares of series A-## convertible preferred stock converted into one share of common stock immediately prior to completion of its initial public offering.

  • Immunology
  • Neurology
  • Pharmaceutical
  • Stroke
  • Amgen Inc.

It offers products such as antirheumatic agent, antibacterial agent, antiviral agent and antifungal agent.

  • Immunology
  • Neurology
  • Pharmaceutical
  • Stroke
  • Eisai Co., Ltd.

CM-AT, WHICH HAS BEEN GRANTED FAST TRACK DESIGNATION BY FDA, IS DESIGNED TO ##. ##. ##. ## ##. ##. ##. ## ENHANCE PROTEIN DIGESTION THEREBY POTENTIALLY RESTORING THE POOL OF ESSENTIAL AMINO ACIDS.

  • Neurological Disorder
  • Neurology
  • Pharmaceutical
  • Therapy
  • Product Initiative

Some of its major products include Bicun, an Edaravone Injection providing treatment for strokes; Endu, an innovative anti-angiogenic drug used in the treatment of non-small cell lung cancer and Iremod, a new drug in the category of Disease Modifying Anti-rheumatic Drugs (" DMARDS"

  • Cancer
  • Neurology
  • Pharmaceutical
  • Stroke
  • HitGen

Merck is a US-based pharmaceutical company, while Santen Pharmaceutical Co., Ltd. is a Japan-based company engaged in the research, development, manufacturing, and marketing of ophthalmic and antirheumatic pharmaceuticals.

  • Diabetes
  • Neurology
  • Pharmaceutical
  • Stroke
  • Merck & Co., Inc.

Some of its major products include Bicun, an Edaravone Injection providing treatment for strokes; Endu, an innovative anti-angiogenic drug used in the treatment of non-small cell lung cancer and Iremod, a new drug in the category of Disease Modifying Anti-rheumatic Drugs (" DMARDS"

  • Immunology
  • Neurology
  • Pharmaceutical
  • Stroke
  • Daiichi Sankyo Company

(USA) ##.

  • Health Services
  • Neurology
  • Stroke
  • United States
  • Market Shares

Each of the ##, ## shares of series A-## convertible preferred stock converted into one share of common stock immediately prior to completion of its initial public offering.

  • Immunology
  • Neurology
  • Pharmaceutical
  • Stroke
  • Amgen Inc.

Some of its major products include Bicun, an Edaravone Injection providing treatment for strokes; Endu, an innovative anti-angiogenic drug used in the treatment of non-small cell lung cancer and Iremod, a new drug in the category of Disease Modifying Anti-rheumatic Drugs (" DMARDS"

  • Immunology
  • Neurology
  • Pharmaceutical
  • Stroke
  • Daiichi Sankyo Company

It offers products such as antirheumatic agent, antibacterial agent, antiviral agent and antifungal agent.

  • Immunology
  • Neurology
  • Pharmaceutical
  • Stroke
  • Eisai Co., Ltd.
  • STROKE - PIPELINE BY SAVARA INC, H1 2018
  • STROKE - PIPELINE BY SHIN POONG PHARMCO LTD, H1 2018

The company provides cardiovascular, psychoneurotic, anti-cancer, antihistamine, antirheumatic and benign prostatic hyperplasia drugs.

  • Neurology
  • Stroke
  • Therapy
  • Company
  • Product Initiative
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H1 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Neurology
  • Stroke
  • United States
  • Company Operations
  • AB Science SA

The prominent features of this report are - ##.

  • Chronic Pain
  • Neurology
  • Stroke
  • World
  • Product Initiative
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H2 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Neurology
  • Stroke
  • Therapy
  • Product Initiative
  • AB Science SA